4C Biomed Israeli Company
4C Biomed combines cutting-edge science, real-world clinical insights and unique autologous cell systems (i.e. cancer and immune cells from the same patient) to drive the development of immuno-oncology therapies. Its lead drug is in a stage of IND-enabling studies and is planned to enter clinical Phase I in 2025.
Health Tech & Life Sciences
Biotechnology
Oncology
Therapeutics
Alternatives
No alternatives listed yet.
Suggest an Alternative
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/4c-biomed
[2]
crunchbase.com
- https://www.crunchbase.com/organization/4c-biomed
External links are provided for reference and verification purposes.